An Open Label Study of the Effect of Adjuvant Treatment With Capecitabine in Combination With Oxaliplatin on Disease-free Survival in Patients With Stage III Colon Cancer
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Colorectal Cancer
Both
Colorectal Cancer
Trial Information
An Open Label Study of the Effect of Adjuvant Treatment With Capecitabine in Combination With Oxaliplatin on Disease-free Survival in Patients With Stage III Colon Cancer
Inclusion Criteria:
- Adult patients, >/= 18 years of age
- Treatment in line with the currently approved indication in the Summary of Product
Characteristics
Exclusion Criteria:
- Contraindications according to the current Summary of Product Characteristics
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Disease-free survival
Outcome Time Frame:
3 years
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
Slovakia: State Institute for the Control of Drugs
Study ID:
ML25526
NCT ID:
NCT01442155
Start Date:
October 2011
Completion Date:
March 2015
Related Keywords:
- Colorectal Cancer
- Colonic Neoplasms
- Colorectal Neoplasms
Name | Location |
|---|
